INGALLS & SNYDER LLC - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 39 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q1 2020$1,364,000
-3.3%
266,473
-13.8%
0.09%
+21.1%
Q4 2019$1,410,000
-24.0%
309,244
+2.0%
0.08%
-16.5%
Q3 2019$1,856,000
+2.3%
303,244
+1.7%
0.09%
+4.6%
Q2 2019$1,815,000
+9.1%
298,077
-0.5%
0.09%
+10.1%
Q1 2019$1,663,000
-7.5%
299,577
-5.7%
0.08%
-16.8%
Q4 2018$1,798,000
-43.7%
317,639
+4.4%
0.10%
-29.6%
Q3 2018$3,196,000304,3680.14%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,006,667$16,053,0002.62%
ARS Investment Partners, LLC 860,002$6,880,0000.84%
Gagnon Advisors, LLC 129,573$1,037,0000.77%
GAGNON SECURITIES LLC 201,698$1,614,0000.58%
PERKINS CAPITAL MANAGEMENT INC 74,500$596,0000.54%
Benchmark Capital Advisors 75,092$601,0000.48%
Cortina Asset Management, LLC 524,388$4,195,0000.21%
Whitegate Investment Counselors, Inc. 11,000$88,0000.02%
Phocas Financial Corp. 20,000$160,0000.01%
ROYCE & ASSOCIATES LP 215,353$1,723,0000.01%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders